MAPT and Alzheimer disease: This model expresses the APP Swedish mutation (K670N/M671L), the PS1 M146V mutation, and the tau P301L mutation-each contributing to the development of AD features such as Aβ plaques, tau hyperphosphorylation, and neurofibrillary tangle formation (Oddo et al., 2003).